ACP5 and triple-negative breast carcinoma: Given that ACP5 is a key gene influencing high RiskScore, we inhibited the expression of ACP5 in MDA-MB-468 and MDA-MB-231 cell lines, and by transwell assay, we could observe the ability of ACP5 to promote the proliferation of triple-negative breast cancer cell lines.